Lonza | LONN - Current Liabilities


Lonza reported CHF3.57B in Current Liabilities for its fiscal semester ending in December of 2025.





Current Liabilities Change Date
Akzo Nobel EUR 4.39B 180M Mar/2026
Alcon AG USD 3B 45M Mar/2026
Almirall EUR 350.64M 52.12M Dec/2025
AstraZeneca USD 32.57B 1.95B Mar/2026
BASF EUR 16.41B 838M Dec/2025
Bayer EUR 33.46B 875M Mar/2026
Beiersdorf EUR 3.51B 261M Dec/2025
Covestro EUR 3.87B 299M Dec/2025
Demant DKK 7.42B 1.63B Dec/2025
Fresenius EUR 8.38B 1.18B Dec/2025
Fresenius Medical Care EUR 6.73B 484.42M Mar/2026
Geberit CHF 854.7M 192.6M Dec/2024
Genmab DKK 1.43B 686M Dec/2025
Givaudan CHF 2.35B 422M Dec/2025
GlaxoSmithKline GBP 22.43B 1.04B Mar/2026
GN Store Nord DKK 4.81B 2.5B Mar/2026
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Johnson Matthey GBP 2.53B 211M Jun/2026
Merck EUR 9.35B 307M Mar/2026
Novartis USD 31.37B 4.1B Mar/2026
Philips EUR 7.43B 78M Mar/2026
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 30.01B 1.66B Mar/2026
Sika AG CHF 3.53B 730M Dec/2025
Smith & Nephew USD 1.54B 236M Dec/2025
Solvay EUR 1.79B 59M Mar/2026
UCB EUR 4.4B 470M Dec/2025